Welcome to our dedicated page for ASM International NV news (Ticker: $ASMIY), a resource for investors and traders seeking the latest updates and insights on ASM International NV stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ASM International NV's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ASM International NV's position in the market.
ASM International has announced a €150 million share buyback program for its common shares. This initiative, commencing on May 15, 2024, and ending by October 15, 2024, aims to reduce ASM's share capital. The buyback will adhere to the authority granted by shareholders during the May 13, 2024, Annual General Meeting. A third party will execute the program. Weekly updates on the program's progress will be provided starting May 21, 2024, on ASM’s website. The repurchased shares will primarily be withdrawn, except for those required to support ongoing share and option programs for employees and board members.
ASM International N.V. announces the voting results of its Annual General Meeting, approving resolutions including annual accounts, dividend, appointment of new board members and CEO, and audit firm. The company's common stock trades on Euronext Amsterdam Stock Exchange.
